Fortitude Family Office »

Alnylam Pharmaceuticals shares owned by Fortitude Family Office

Quarter-by-quarter ownership of Alnylam Pharmaceuticals (ALNY) shares owned by Fortitude Family Office from 13F filings

Historical chart of Fortitude Family Office investment in Alnylam Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Alnylam Pharmaceuticals held by Fortitude Family Office consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Alnylam Pharmaceuticals by Fortitude Family Office

Quarter filed Position value Share count Share price at filing
2025-09-30 $236k 517 456.00
2025-06-30 $169k 517 326.09
2025-03-31 $135k 500 270.02
2024-12-31 $0 0 0.00
2024-09-30 $3.9k 14 275.00

More positions owned by Fortitude Family Office

Ishares Core S&p 500 Etf Etf (IVV)
Ishares Core Msci International Developed Markets Etf Etf (IDEV)
Apple Stock (AAPL)
Wisdomtree Floating Rate Treasury Fund Etf (USFR)
Vanguard Ftse Developed Markets Etf Etf (VEA)
Vanguard S&p 500 Etf Etf (VOO)
Dimensional Inflation-protected Securities Etf Etf (DFIP)
Vanguard Mid-cap Etf Etf (VO)
Knight-swift Transn Hldgs Inc Cl A Stock (KNX)
Imgp Dbi Managed Futures Strategy Etf Etf (DBMF)
Ishares Core Msci Emerging Markets Etf Etf (IEMG)
Dimensional Emerging Markets Core Equity 2 Etf Etf (DFEM)
Avantis U.s. Large Cap Value Etf Etf (AVLV)
Ishares U.s. Technology Etf Etf (IYW)
Ishares Core S&p Mid-cap Etf Etf (IJH)

View all positions for Fortitude Family Office

Top funds holding Alnylam Pharmaceuticals

FMR
Capital World Investors
Vanguard Group
BlackRock
Capital Research Global Investors
Jpmorgan Chase & Co
Groupama Asset Managment
State Street Corporation
Baillie Gifford & Co
Geode Capital Management
Dodge & Cox
T. Rowe Price Investment Management
Orbis Allan Gray
Wellington Management Company
Susquehanna International

View all funds holding Alnylam Pharmaceuticals